share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股SEC公告 ·  11/02 03:27

牛牛AI助理已提取核心訊息

Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on October 31, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction was associated with Pfizer's stock, trading under the symbol PFE on the stock market.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on October 31, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction was associated with Pfizer's stock, trading under the symbol PFE on the stock market.
輝瑞公司(PFE)董事長兼首席執行官艾伯特·伯拉執行了一項交易,時間爲2024年10月31日。公告中沒有披露交易的具體細節,包括交易的股份數量、股票性質、交易價格和股份的總價值。報告還未提供伯拉交易後持有的股份數量。此次交易涉及輝瑞公司的股票,該股票在股市上以PFE標的進行交易。
輝瑞公司(PFE)董事長兼首席執行官艾伯特·伯拉執行了一項交易,時間爲2024年10月31日。公告中沒有披露交易的具體細節,包括交易的股份數量、股票性質、交易價格和股份的總價值。報告還未提供伯拉交易後持有的股份數量。此次交易涉及輝瑞公司的股票,該股票在股市上以PFE標的進行交易。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。